Ginkgo Bioworks Holdings Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About DNA
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The Company provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.
Find out what a historical investment in Ginkgo Bioworks Holdings Inc would be worth today using our DNA stock calculator.
$441.37M
-
0.00%
835.63K
$8.03
$7.36
$8.03
$45.20
$5.00
Ready to start your investing journey with Stake?
Open an accountDNA FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in DNA
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DNA
on Stake
Buy DNA from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of DNA from only US$10 with fractional shares
